Loading clinical trials...
Loading clinical trials...
A Randomized, Open Labeled Comparative Study to Assess the Efficacy and Safety of Controller Medications as Add on to Inhaled Steroid and Long Acting β2 Agonist in Treatment of Moderate to Severe Persistent Bronchial Asthma
Conditions
Interventions
inhaled budesonide and formeterol plus oral montelukast
inhaled budesonide and formeterol plus oral doxophylline
+1 more
Locations
1
India
Sir Takthasinhji General Hospital Bhavnagar, Gujarat, India
Bhavnagar, Gujarat, India
Start Date
December 1, 2008
Primary Completion Date
June 1, 2009
Completion Date
July 1, 2009
Last Updated
January 25, 2010
Lead Sponsor
Government Medical College, Bhavnagar
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions